AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2012
Nov 14, 2012
3174_iss_2012-11-14_c9605068-9e07-4627-800e-218a9bd5c9ce.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Mohammed Al Amoudi
Instrument
| Instrument | aktie SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 499,700 |
| Voting rights | 499,700 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 13/11/2012 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 492,475 |
| Directly held voting rights | 492,475 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.93 % |
| Directly held voting rights | 4.93 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | ||
Published
14/11/2012 13:08
Contact
Name Oscar Ahlgren Phone 040-200251 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13